Hunter Hall are not buyers (nor sellers) since no announcements
no-one else has bought a significant stake in the frenzy of the last 3 weeks, suggesting mostly traders not investors
no-one bothered with a takeover when they had a chance. There was a time not so long ago that a 66 cps offer would have been a 100% premium to the share price.
why would GSK spend to buy 7% royalty when they already have 93% for nothing.
remember LANI royalty for ROW will be split with Sankyo, so BTA's share probably won't be much more than 5%: not many double digit royalties out there.
BTA Price at posting:
$1.10 Sentiment: Hold Disclosure: Held
